Overview

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants

Status:
Not yet recruiting
Trial end date:
2020-11-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the way the body absorbs, distributes, breaks down and eliminates radioactive BMS-986278 as well as the safety and tolerability of BMS-986278 in healthy male participants.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb